Cargando…
Novel glycopolymer sensitizes Burkholderia cepacia complex isolates from cystic fibrosis patients to tobramycin and meropenem
Burkholderia cepacia complex (Bcc) infection, associated with cystic fibrosis (CF) is intrinsically multidrug resistant to antibiotic treatment making eradication from the CF lung virtually impossible. Infection with Bcc leads to a rapid decline in lung function and is often a contraindication for l...
Autores principales: | Narayanaswamy, Vidya P., Giatpaiboon, Scott, Baker, Shenda M., Wiesmann, William P., LiPuma, John J., Townsend, Stacy M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5491046/ https://www.ncbi.nlm.nih.gov/pubmed/28662114 http://dx.doi.org/10.1371/journal.pone.0179776 |
Ejemplares similares
-
In Vitro Activity of a Novel Glycopolymer against Biofilms of Burkholderia cepacia Complex Cystic Fibrosis Clinical Isolates
por: Narayanaswamy, Vidya P., et al.
Publicado: (2019) -
Polycationic Glycopolymer Demonstrates Activity Against Persisters and Biofilms of Non-tuberculosis Mycobacteria Cystic Fibrosis Clinical Isolates in vitro
por: Narayanaswamy, Vidya P., et al.
Publicado: (2022) -
In Vitro activity of novel glycopolymer against clinical isolates of multidrug-resistant Staphylococcus aureus
por: Narayanaswamy, Vidya P., et al.
Publicado: (2018) -
Novel Glycopolymer Eradicates Antibiotic- and CCCP-Induced Persister Cells in Pseudomonas aeruginosa
por: Narayanaswamy, Vidya P., et al.
Publicado: (2018) -
Commercial use of Burkholderia cepacia.
por: LiPuma, J J, et al.
Publicado: (1999)